Genetic variants in SLC9A9 are associated with measures of attention-deficit/hyperactivity disorder symptoms in families - PubMed (original) (raw)

Folate intake and colorectal cancer risk according to genetic subtypes defined by targeted tumor sequencing.

Aglago EK, Qu C, Harlid S, Phipps AI, Steinfelder RS, Ogino S, Thomas CE, Hsu L, Toland AE, Brenner H, Berndt SI, Buchanan DD, Campbell PT, Cao Y, Chan AT, Drew DA, Figueiredo JC, French AJ, Gallinger S, Georgeson P, Giannakis M, Goode EL, Gruber SB, Gunter MJ, Harrison TA, Hoffmeister M, Huang WY, Hullar MA, Huyghe JR, Jenkins MA, Lynch BM, Moreno V, Murphy N, Newton CC, Nowak JA, Obón-Santacana M, Sun W, Ugai T, Um CY, Zaidi SH, Tsilidis KK, van Guelpen B, Peters U. Aglago EK, et al. Am J Clin Nutr. 2024 Sep;120(3):664-673. doi: 10.1016/j.ajcnut.2024.07.012. Epub 2024 Jul 16. Am J Clin Nutr. 2024. PMID: 39025327 Free PMC article.

Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer's disease related proteins.

Oatman SR, Reddy JS, Quicksall Z, Carrasquillo MM, Wang X, Liu CC, Yamazaki Y, Nguyen TT, Malphrus K, Heckman M, Biswas K, Nho K, Baker M, Martens YA, Zhao N, Kim JP, Risacher SL, Rademakers R, Saykin AJ, DeTure M, Murray ME, Kanekiyo T; Alzheimer’s Disease Neuroimaging Initiative; Dickson DW, Bu G, Allen M, Ertekin-Taner N. Oatman SR, et al. Mol Neurodegener. 2023 Jan 7;18(1):2. doi: 10.1186/s13024-022-00592-2. Mol Neurodegener. 2023. PMID: 36609403 Free PMC article.